Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Jacobsen, Frank, Taskin, Billurvan, Melling, Nathaniel, Sauer, Charlotte, Wittmer, Corinna, Hube-Magg, Claudia, Kluth, Martina, Simon, Ronald, Pehrke, Dirk, Beyer, Burkhard
et al (show 8 more authors) (2017) Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer. BMC CANCER, 17 (1). 504-.


Jones, Robert P ORCID: 0000-0001-5608-001X, Mielgo, Ainhoa, Schmid, Michael ORCID: 0000-0002-3445-0013, Bury, Danielle, Andrews, Timothy, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Shackcloth, Michael, J. S. Cross, Timothy, Fenwick, Stephen, Malik, Hassan Z
et al (show 4 more authors) (2023) PINCER (A Platform Study for solId orgaN CancERs): an agile pan-network platform study to deliver high-quality translational research. BRITISH JOURNAL OF SURGERY, 110 (9). pp. 1108-1111.


Elsesy, Mohamed E, Oh-Hohenhorst, Su Jung, Oing, Christoph, Eckhardt, Alicia, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Alawi, Malik, Mueller, Christian, Schueller, Ulrich, Maurer, Tobias, von Amsberg, Gunhild
et al (show 3 more authors) (2023) Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease. MOLECULAR ONCOLOGY, 17 (6). pp. 1129-1147.


Grupp, Katharina, Hofmann, Bianca, Kutup, Asad, Bachmann, Kai, Bogoevski, Dean, Melling, Nathaniel, Uzunoglu, Faik Guntac, El Gammal, Alexander Tarek, Koop, Christina, Simon, Ronald
et al (show 7 more authors) (2018) Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome. BMC CANCER, 18 (1). 1106-.


Elsesy, Mohamed E, Oh-Hohenhorst, Su Jung, Loeser, Anastassia, Oing, Christoph, Mutiara, Sally, Koecher, Sabrina, Meien, Stefanie, Zielinski, Alexandra, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Tilki, Derya
et al (show 6 more authors) (2020) Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair. CANCERS, 12 (9). E2467-.

This list was generated on Sun Feb 25 05:21:16 2024 GMT.